ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50989
0.00%
Bitcoin
60,823.54
0.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Hercules Capital Inc (HTGC)

  7. Hercules Capital Inc (HTGC) News

HTGC

Hercules Capital (HTGC)

Hercules Capital Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:HTGC
DateTimeSourceHeadlineSymbolCompany
09/05/202421:00GlobeNewswire Inc.Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERSNYSE:HTGCHercules Capital Inc
07/05/202420:00Business WireHercules Capital Announces Upcoming Event for the Financial CommunityNYSE:HTGCHercules Capital Inc
03/05/202406:05Business WireHercules Capital Reports First Quarter 2024 Financial ResultsNYSE:HTGCHercules Capital Inc
30/04/202420:00Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024NYSE:HTGCHercules Capital Inc
30/04/202417:00PR Newswire (US)SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabNYSE:HTGCHercules Capital Inc
30/04/202417:00PR Newswire (US)SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabNYSE:HTGCHercules Capital Inc
24/04/202420:00Business WireHercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative OriginationsNYSE:HTGCHercules Capital Inc
18/04/202420:00Business WireHercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
27/03/202421:00Business WireHercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.NYSE:HTGCHercules Capital Inc
21/03/202421:00Business WireHercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRSNYSE:HTGCHercules Capital Inc
20/02/202422:00Business WireHercules Capital Announces Upcoming Event for the Financial CommunityNYSE:HTGCHercules Capital Inc
16/02/202408:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:HTGCHercules Capital Inc
16/02/202408:07Business WireHercules Capital Reports Fourth Quarter and Full-Year 2023 Financial ResultsNYSE:HTGCHercules Capital Inc
13/02/202422:02Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023NYSE:HTGCHercules Capital Inc
13/02/202422:00Business WireHercules Capital Announces New Supplemental Cash Distribution of $0.32 per ShareNYSE:HTGCHercules Capital Inc
31/01/202409:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
31/01/202409:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
31/01/202409:39Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
25/01/202422:00Business WireHercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
24/01/202408:05GlobeNewswire Inc.Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules CapitalNYSE:HTGCHercules Capital Inc
23/01/202403:23Edgar (US Regulatory)Form ABS-15G - Asset-backed securitizer report pursuant to Section 15GNYSE:HTGCHercules Capital Inc
18/01/202411:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
18/01/202411:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
18/01/202411:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202412:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202412:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202412:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202412:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
13/01/202410:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
11/01/202408:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
 Showing the most relevant articles for your search:NYSE:HTGC

Your Recent History

ASX
XFL
S&P ASX 50
FX
AUDUSD
AUD vs US Dollar
FTSE
UKX
FTSE 100
ASX
MQG
Macquarie
FX
AUDJPY
AUD vs Yen
ASX
TLS
Telstra
ASX
NAB
National Australia Bank
ASX
WES
Wesfarmers
ASX
QBE
QBE Insurance
ASX
BHP
BHP
ASX
XMM
S&P ASX 300 Metals and M...
COIN
BTCUSD
Bitcoin
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved